Younes Maged, Aquilina Gabriele, Castle Laurence, Degen Gisela, Engel Karl-Heinz, Fowler Paul J, Frutos Fernandez Maria Jose, Fürst Peter, Gürtler Rainer, Husøy Trine, Manco Melania, Mennes Wim, Moldeus Peter, Passamonti Sabina, Shah Romina, Waalkens-Berendsen Ine, Wright Matthew, Wölfle Detlef, Dusemund Birgit, Mortensen Alicja, Turck Dominique, Cheyns Karlien, Gaffet Eric, Loeschner Katrin, Mast Jan, Mirat Manuela, Undas Anna, Barmaz Stefania, Mech Agnieszka, Rincon Ana Maria, Smeraldi Camilla, Tard Alexandra, Gundert-Remy Ursula
EFSA J. 2023 Jul 27;21(7):e08106. doi: 10.2903/j.efsa.2023.8106. eCollection 2023 Jul.
Calcium carbonate (E 170) was re-evaluated in 2011 by the former EFSA Panel on Food Additives and Nutrient sources added to Food (ANS). As a follow-up to this assessment, the Panel on Food Additives and Flavourings (FAF) was requested to assess the safety of calcium carbonate (E 170) for its uses as a food additive in food for infants below 16 weeks of age belonging to food category 13.1.5.1 (Dietary foods for infants for special medical purposes and special formulae for infants) and as carry over in line with Annex III, Part 5 Section B to Regulation (EC) No 1333/2008. In addition, the FAF Panel was requested to address the issues already identified during the re-evaluation of the food additive when used in food for the general population. The process involved the publication of a call for data to allow the interested business operators (IBOs) to provide the requested information to complete the risk assessment. The Panel concluded that there is no need for a numerical acceptable daily intake (ADI) for calcium carbonate and that, in principle, there are no safety concern with respect to the exposure to calcium carbonate at the currently reported uses and use levels in all age groups of the population, including infants below 16 weeks of age. With respect to the calcium intake resulting from the use of E 170 in food for the general population and infants < 16 weeks of age, the Panel concluded that it contributes only to a small part to the overall calcium dietary exposure. However, the unavoidable presence of aluminium in E 170 is of concern and should be addressed. In addition, the Panel concluded that the technical data provided by the IBO support further amendments of the specifications for E 170 laid down in Commission Regulation (EU) No 231/2012.
碳酸钙(E 170)于2011年由前欧洲食品安全局食品添加剂和添加到食品中的营养源专家委员会(ANS)进行了重新评估。作为此次评估的后续行动,要求食品添加剂和香料专家委员会(FAF)评估碳酸钙(E 170)作为食品添加剂在属于食品类别13.1.5.1(特殊医学用途婴儿膳食食品和婴儿特殊配方食品)的16周龄以下婴儿食品中的安全性,以及根据欧盟第1333/2008号法规附件III第5部分B节作为残留量的安全性。此外,要求FAF专家委员会处理在对该食品添加剂用于一般人群食品的重新评估过程中已经确定的问题。该过程包括发布数据征集通知,以使感兴趣的商业经营者(IBO)提供所需信息以完成风险评估。专家委员会得出结论,碳酸钙无需设定数值化的每日允许摄入量(ADI),并且原则上,就目前报告的在所有年龄组人群(包括16周龄以下婴儿)中的使用和使用水平而言,接触碳酸钙不存在安全问题。关于在一般人群食品和16周龄以下婴儿食品中使用E 170所导致的钙摄入量,专家委员会得出结论,其仅占总体膳食钙摄入量的一小部分。然而,E 170中不可避免存在的铝令人担忧,应予以解决。此外,专家委员会得出结论,IBO提供的技术数据支持对欧盟委员会第231/2012号法规中规定的E 170规格进行进一步修订。